MedTrace Logo

Effects of Exoskeleton-Assisted Gait Training on Bone Health and Quality of Life

NCT02533713 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2021-12-08

No results posted yet for this study

Summary

This is a randomized clinical trial to quantify the effects of exoskeleton-assisted gait on the musculoskeletal system and health-related quality of life.

Conditions

Interventions

DEVICE

Exoskeleton assisted gait training

Gait training will be performed 3 times a week for about an hour for 26 weeks. Gait training will be performed by a trained clinical physical therapist. The goal is to achieve 1 hour of continuous walking on a flat surface per training session. Gait training will continue for 26 weeks (78 sessions).

Sponsors & Collaborators

  • Worcester Polytechnic Institute

    collaborator OTHER

  • Massachusetts General Hospital

    collaborator OTHER

  • University of Colorado, Denver

    collaborator OTHER

  • University of Minnesota

    collaborator OTHER

  • Craig Hospital

    lead OTHER

Principal Investigators

  • Leslie R Morse, DO · Craig Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2022-10-31
Completion
2022-12-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02533713 on ClinicalTrials.gov